Jun. 18, 2009- Initiative Focuses on Role of Gastric Bypass Surgery in Resolving Type 2 Diabetes - As the rate of Type 2 Diabetes soars to epidemic proportions worldwide, Covidien (NYSE: COV), a leading global provider of healthcare products, announced the launch of the Our Resolution movement, a collaboration of healthcare experts, nonprofit organizations, health agencies, patients and national spokespersons who share the goal of resolving Type 2 Diabetes.According to the World Health Organization, the worldwide incidence of Type 2 Diabetes is projected to grow from 171 million cases currently to 366 million worldwide by 2030. In 2007, the overall economic cost of diabetes in the U.S. was estimated at $174 billion.
The Our Resolution movement specifically focuses on the discovery that gastric bypass surgery resolves Type 2 Diabetes in approximately 77 percent of morbidly obese patients. In fact, for many of these patients, their diabetes or need for medication is resolved within days of surgery. According to the American Society for Metabolic and Bariatric Surgery, approximately 220,000 people in the U.S. had bariatric surgery in 2008. Studies show that those who had surgery dramatically reduced their risk of dying from an obesity-related disease, including the risk of death from diabetes, (down 92 percent), cancer (down 60 percent) and coronary artery disease (down 56 percent)... Covidien's Press Release -
